Table 1.
Clinicopathological parameters of lung cancer patients between CCNB1 high and low expression groups
| Variables | Number of patients | P | |
|---|---|---|---|
|
| |||
| CCNB1 high-expression group | CCNB1 low-expression group | ||
| Number | 41 | 42 | 0.913 |
| Age (years) | 0.915 | ||
| >70 | 7 | 5 | |
| 55-70 | 20 | 25 | |
| <55 | 14 | 12 | |
| Gender | 0.012 | ||
| Female | 26 | 15 | |
| Male | 15 | 27 | |
| Smoking (pack/year) | 0.002 | ||
| None | 17 | 7 | |
| 1-20 | 3 | 2 | |
| 20-50 | 8 | 6 | |
| >50 | 13 | 27 | |
| T stage | 0.012 | ||
| T1 | 19 | 7 | |
| T2 | 18 | 30 | |
| T3 | 4 | 4 | |
| T4 | 0 | 1 | |
| N stage | 0.019 | ||
| N0 | 29 | 20 | |
| N1 | 10 | 14 | |
| N2 | 2 | 8 | |
| Metastases | 0.986 | ||
| No | 40 | 41 | |
| Yes | 1 | 1 | |
| TNM stage | 0.033 | ||
| I | 18 | 12 | |
| II | 21 | 20 | |
| III | 1 | 9 | |
| IV | 1 | 1 | |